Yu‐Ping Zhou

447 total citations
21 papers, 212 citations indexed

About

Yu‐Ping Zhou is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yu‐Ping Zhou has authored 21 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yu‐Ping Zhou's work include Pulmonary Hypertension Research and Treatments (9 papers), Glycosylation and Glycoproteins Research (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Yu‐Ping Zhou is often cited by papers focused on Pulmonary Hypertension Research and Treatments (9 papers), Glycosylation and Glycoproteins Research (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Yu‐Ping Zhou collaborates with scholars based in China, United Kingdom and Belgium. Yu‐Ping Zhou's co-authors include Zhi‐Cheng Jing, Yi Yan, Yunpeng Wei, Xin Jiang, Hui‐Fang Wang, Zejian Zhang, Yixuan Wang, Xi‐Qi Xu, Kai Sun and Fu-Hua Peng and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Yu‐Ping Zhou

20 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Ping Zhou China 9 75 74 50 29 24 21 212
Genji Yamaoka Japan 14 111 1.5× 24 0.3× 45 0.9× 65 2.2× 20 0.8× 22 345
Asmita Pant United States 9 51 0.7× 43 0.6× 27 0.5× 23 0.8× 21 0.9× 18 258
Nathalie Donnadieu France 9 51 0.7× 79 1.1× 29 0.6× 11 0.4× 11 0.5× 13 217
Yueyan Li China 8 123 1.6× 42 0.6× 28 0.6× 14 0.5× 47 2.0× 26 215
Prabhash Kumar Jha India 9 114 1.5× 18 0.2× 26 0.5× 33 1.1× 70 2.9× 17 236
Atta Nawabi United States 8 128 1.7× 43 0.6× 23 0.5× 38 1.3× 17 0.7× 20 312
Ryoichi Kyuragi Japan 11 60 0.8× 132 1.8× 51 1.0× 27 0.9× 9 0.4× 31 284
Shengliang Ye China 10 113 1.5× 20 0.3× 11 0.2× 30 1.0× 25 1.0× 28 273
S. Spinelli United States 9 125 1.7× 20 0.3× 27 0.5× 39 1.3× 11 0.5× 18 329

Countries citing papers authored by Yu‐Ping Zhou

Since Specialization
Citations

This map shows the geographic impact of Yu‐Ping Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ping Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ping Zhou more than expected).

Fields of papers citing papers by Yu‐Ping Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ping Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ping Zhou. The network helps show where Yu‐Ping Zhou may publish in the future.

Co-authorship network of co-authors of Yu‐Ping Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ping Zhou. A scholar is included among the top collaborators of Yu‐Ping Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ping Zhou. Yu‐Ping Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Jiayong, Chao Liu, Yuejiao Ma, et al.. (2025). Pulmonary arterial hypertension: a long-standing and nonnegligible burden over three decades. Science Bulletin. 70(11). 1766–1769. 1 indexed citations
2.
Wang, Anyi, Yue Cui, Chao Liu, et al.. (2025). Growth Differentiation Factor-15 Improves Prognostic Accuracy of Risk Stratification in Pulmonary Arterial Hypertension. CHEST Journal. 169(3). 758–768.
3.
Zhang, Kaili, et al.. (2023). Subcutaneous and Orbital Adipose Tissues: Intrinsic Differences in Carotenoid Contents and Lipidomic Compositions. ACS Omega. 8(31). 28052–28059. 3 indexed citations
4.
Zhang, Zejian, Hui‐Fang Wang, Tian‐Yu Lian, et al.. (2023). Human Plasma IgG N -Glycome Profiles Reveal a Proinflammatory Phenotype in Chronic Thromboembolic Pulmonary Hypertension. Hypertension. 80(9). 1929–1939. 9 indexed citations
5.
Zhu, Yongjian, Yu‐Ping Zhou, Chun‐Yan Cheng, et al.. (2023). Percutaneous transluminal pulmonary angioplasty for Takayasu arteritis‐associated pulmonary hypertension: A single‐arm meta‐analysis. Catheterization and Cardiovascular Interventions. 102(3). 558–567. 1 indexed citations
6.
He, Yangzhige, Ruonan Li, Jia Wang, et al.. (2023). MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension. Vascular Pharmacology. 153. 107216–107216. 2 indexed citations
7.
Cheng, Chun‐Yan, Yongjian Zhu, Yu‐Ping Zhou, et al.. (2023). Heart Rate Response Predicts 6-Minutes Walking Distance in Pulmonary Arterial Hypertension. The American Journal of Cardiology. 204. 207–214. 1 indexed citations
8.
Zhang, Cuiyu, Yu‐Ping Zhou, Nannan Ning, et al.. (2022). Inhibition of GABAA receptors in intestinal stem cells prevents chemoradiotherapy-induced intestinal toxicity. The Journal of Experimental Medicine. 219(12). 14 indexed citations
9.
Tang, Chunlan, et al.. (2022). Yangyinqingfei decoction attenuates PM2.5-induced lung injury by enhancing arachidonic acid metabolism. Frontiers in Pharmacology. 13. 1056078–1056078. 9 indexed citations
10.
Wang, Hui‐Fang, Yixuan Wang, Yu‐Ping Zhou, et al.. (2022). Protein O-GlcNAcylation in cardiovascular diseases. Acta Pharmacologica Sinica. 44(1). 8–18. 31 indexed citations
11.
Lian, Tian‐Yu, Jianzhou Liu, Yu‐Ping Zhou, et al.. (2022). Prevalence, Genetic Background, and Clinical Phenotype of Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension. JACC Asia. 2(3). 247–255. 2 indexed citations
12.
Zhou, Yu‐Ping, Yunpeng Wei, Xi‐Qi Xu, et al.. (2022). Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension. Journal of the American College of Cardiology. 79(15). 1477–1488. 10 indexed citations
13.
Zhou, Yu‐Ping, et al.. (2022). Anesthetic injection pain and hematoma occurrence during upper blepharoplasty: Comparison between thin needles and thick needles. SHILAP Revista de lepidopterología. 4(2). 63–66. 1 indexed citations
14.
Liu, Ying, Yu‐Ping Zhou, Mai Zhang, et al.. (2021). Clinicopathologic Characteristics and Outcomes of Simultaneous Multiple Primary Lung Cancer. Journal of Oncology. 2021. 1–9. 5 indexed citations
15.
Zhu, Yongjian, Yu‐Ping Zhou, Yunpeng Wei, et al.. (2021). Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension. Frontiers in Cardiovascular Medicine. 8. 628284–628284. 7 indexed citations
16.
He, Yangyang, Yi Yan, Xin Jiang, et al.. (2020). Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension. European Respiratory Journal. 56(5). 2000522–2000522. 47 indexed citations
17.
Liu, Wendong, Changjun Bao, Yu‐Ping Zhou, et al.. (2019). Forecasting incidence of hand, foot and mouth disease using BP neural networks in Jiangsu province, China. BMC Infectious Diseases. 19(1). 828–828. 30 indexed citations
18.
Jiang, Xin, Chun‐Yan Cheng, Gentian Denas, et al.. (2019). Antiphospholipid Syndrome in Chronic Thromboembolic Pulmonary Hypertension: A Well-Defined Subgroup of Patients. Thrombosis and Haemostasis. 119(9). 1403–1408. 22 indexed citations
19.
Zhang, Yixin, Lan Wang, Ping Yuan, et al.. (2019). Association Between High FSH, Low Progesterone, and Idiopathic Pulmonary Arterial Hypertension in Women of Reproductive Age. American Journal of Hypertension. 33(1). 99–105. 5 indexed citations
20.
Zhou, Yu‐Ping, Xia Qin, Xi Wang, & Shukun Fu. (2018). Endotoxin Tolerant Dendritic Cells Suppress Inflammatory Responses in Splenocytes via Interleukin-1 Receptor Associated Kinase (IRAK)-M and Programmed Death-Ligand 1 (PDL-1). Medical Science Monitor. 24. 4798–4806. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Genji Yamaoka Breakdown of academic impact, for papers by Asmita Pant Breakdown of academic impact, for papers by Nathalie Donnadieu Breakdown of academic impact, for papers by Yueyan Li Breakdown of academic impact, for papers by Prabhash Kumar Jha Breakdown of academic impact, for papers by Atta Nawabi Breakdown of academic impact, for papers by Ryoichi Kyuragi Breakdown of academic impact, for papers by Shengliang Ye Breakdown of academic impact, for papers by S. Spinelli
Rankless by CCL
2026